28210222|t|Icariside II, a Broad-Spectrum Anti-cancer Agent, Reverses Beta-Amyloid-Induced Cognitive Impairment through Reducing Inflammation and Apoptosis in Rats.
28210222|a|Beta-amyloid (Abeta) deposition, associated neuronal apoptosis and neuroinflammation are considered as the important factors which lead to cognitive deficits in Alzheimer's disease (AD). Icariside II (ICS II), an active flavonoid compound derived from Epimedium brevicornum Maxim, has been extensively used to treat erectile dysfunction, osteoporosis and dementia in traditional Chinese medicine. Recently, ICS II attracts great interest due to its broad-spectrum anti-cancer property. ICS II shows an anti-inflammatory potential both in cancer treatment and cerebral ischemia-reperfusion. It is not yet clear whether the anti-inflammatory effect of ICS II could delay progression of AD. Therefore, the current study aimed to investigate the effects of ICS II on the behavioral deficits, Abeta levels, neuroinflammatory responses and apoptosis in Abeta25-35-treated rats. We found that bilateral hippocampal injection of Abeta25-35 induced cognitive impairment, neuronal damage, along with increase of Abeta, inflammation and apoptosis in hippocampus of rats. However, treatment with ICS II 20 mg/kg could improve the cognitive deficits, ameliorate neuronal death, and reduce the levels of Abeta in the hippocampus. Furthermore, ICS II could suppress microglial and astrocytic activation, inhibit expression of IL-1beta, TNF-alpha, COX-2, and iNOS mRNA and protein, and attenuate the Abeta induced Bax/Bcl-2 ratio elevation and caspase-3 activation. In conclusion, these results showed that ICS II could reverse Abeta-induced cognitive deficits, possibly via the inhibition of neuroinflammation and apoptosis, which suggested a potential protective effect of ICS II on AD.
28210222	0	12	Icariside II	Chemical	MESH:C060988
28210222	35	42	-cancer	Disease	MESH:D009369
28210222	80	100	Cognitive Impairment	Disease	MESH:D003072
28210222	118	130	Inflammation	Disease	MESH:D007249
28210222	148	152	Rats	Species	10116
28210222	168	173	Abeta	Gene	54226
28210222	221	238	neuroinflammation	Disease	MESH:D000090862
28210222	293	311	cognitive deficits	Disease	MESH:D003072
28210222	315	334	Alzheimer's disease	Disease	MESH:D000544
28210222	336	338	AD	Disease	MESH:D000544
28210222	341	353	Icariside II	Chemical	MESH:C060988
28210222	355	361	ICS II	Chemical	MESH:C060988
28210222	374	383	flavonoid	Chemical	MESH:D005419
28210222	406	433	Epimedium brevicornum Maxim	Species	
28210222	470	490	erectile dysfunction	Disease	MESH:D007172
28210222	492	504	osteoporosis	Disease	MESH:D010024
28210222	509	517	dementia	Disease	MESH:D003704
28210222	561	567	ICS II	Chemical	MESH:C060988
28210222	623	629	cancer	Disease	MESH:D009369
28210222	640	646	ICS II	Chemical	MESH:C060988
28210222	661	673	inflammatory	Disease	MESH:D007249
28210222	692	698	cancer	Disease	MESH:D009369
28210222	713	730	cerebral ischemia	Disease	MESH:D002545
28210222	781	793	inflammatory	Disease	MESH:D007249
28210222	804	810	ICS II	Chemical	MESH:C060988
28210222	838	840	AD	Disease	MESH:D000544
28210222	907	913	ICS II	Chemical	MESH:C060988
28210222	921	940	behavioral deficits	Disease	MESH:D019958
28210222	942	947	Abeta	Gene	54226
28210222	956	973	neuroinflammatory	Disease	MESH:D000090862
28210222	1020	1024	rats	Species	10116
28210222	1094	1114	cognitive impairment	Disease	MESH:D003072
28210222	1116	1131	neuronal damage	Disease	MESH:D009410
28210222	1156	1161	Abeta	Gene	54226
28210222	1163	1175	inflammation	Disease	MESH:D007249
28210222	1208	1212	rats	Species	10116
28210222	1238	1244	ICS II	Chemical	MESH:C060988
28210222	1272	1290	cognitive deficits	Disease	MESH:D003072
28210222	1303	1317	neuronal death	Disease	MESH:D009410
28210222	1344	1349	Abeta	Gene	54226
28210222	1383	1389	ICS II	Chemical	MESH:C060988
28210222	1465	1473	IL-1beta	Gene	24494
28210222	1475	1484	TNF-alpha	Gene	24835
28210222	1486	1491	COX-2	Gene	26198
28210222	1497	1501	iNOS	Gene	24599
28210222	1538	1543	Abeta	Gene	54226
28210222	1552	1555	Bax	Gene	24887
28210222	1556	1561	Bcl-2	Gene	24224
28210222	1582	1591	caspase-3	Gene	25402
28210222	1645	1651	ICS II	Chemical	MESH:C060988
28210222	1666	1671	Abeta	Gene	54226
28210222	1680	1698	cognitive deficits	Disease	MESH:D003072
28210222	1731	1748	neuroinflammation	Disease	MESH:D000090862
28210222	1813	1819	ICS II	Chemical	MESH:C060988
28210222	1823	1825	AD	Disease	MESH:D000544
28210222	Negative_Correlation	MESH:C060988	MESH:D007249
28210222	Negative_Correlation	MESH:C060988	MESH:D000544
28210222	Negative_Correlation	MESH:C060988	MESH:D010024
28210222	Negative_Correlation	MESH:C060988	MESH:D003072
28210222	Negative_Correlation	MESH:C060988	24599
28210222	Negative_Correlation	MESH:C060988	MESH:D009410
28210222	Negative_Correlation	MESH:C060988	MESH:D007172
28210222	Association	MESH:D000544	54226
28210222	Negative_Correlation	MESH:C060988	24494
28210222	Negative_Correlation	MESH:C060988	24887
28210222	Negative_Correlation	MESH:C060988	MESH:D000090862
28210222	Negative_Correlation	MESH:C060988	24835
28210222	Negative_Correlation	MESH:C060988	MESH:D009369
28210222	Negative_Correlation	MESH:C060988	26198
28210222	Positive_Correlation	MESH:C060988	25402
28210222	Negative_Correlation	MESH:C060988	54226
28210222	Negative_Correlation	MESH:C060988	24224
28210222	Negative_Correlation	MESH:C060988	MESH:D002545
28210222	Negative_Correlation	MESH:C060988	MESH:D019958
28210222	Positive_Correlation	24887	54226
28210222	Positive_Correlation	MESH:D003072	54226
28210222	Negative_Correlation	MESH:C060988	MESH:D003704

